bioAffinity Technologies, Inc. (BIAF)
BIAF Stock Price Chart
Explore bioAffinity Technologies, Inc. interactive price chart. Choose custom timeframes to analyze BIAF price movements and trends.
BIAF Company Profile
Discover essential business fundamentals and corporate details for bioAffinity Technologies, Inc. (BIAF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
1 Sept 2022
Employees
57.00
Website
https://www.bioaffinitytech.comCEO
Maria Zannes
Description
As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.
BIAF Financial Timeline
Browse a chronological timeline of bioAffinity Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 19 Aug 2026
EPS estimate is -$2.10, while revenue estimate is $1.70m.
Earnings released on 8 May 2026
EPS came in at -$0.81 surpassing the estimated -$2.40 by +66.25%, while revenue for the quarter reached $1.35m , missing expectations by -8.87%.
Earnings released on 13 Mar 2026
EPS came in at -$1.11 surpassing the estimated -$2.70 by +58.89%, while revenue for the quarter reached $1.59m , beating expectations by +2.51%.
Earnings released on 14 Nov 2025
EPS came in at -$2.70 matching the estimated -$2.70, while revenue for the quarter reached $1.45m , beating expectations by +2.49%.
Stock split effective on 19 Sept 2025
Shares were split 1 : 30 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2025
EPS came in at -$3.90 falling short of the estimated -$2.70 by -44.44%, while revenue for the quarter reached $1.27m , missing expectations by -10.03%.
Earnings released on 15 May 2025
EPS came in at -$0.16 matching the estimated -$0.16, while revenue for the quarter reached $1.85m , beating expectations by +53.73%.
Earnings released on 31 Mar 2025
EPS came in at -$0.21 falling short of the estimated -$0.14 by -50.00%, while revenue for the quarter reached $2.21m , missing expectations by -8.68%.
Earnings released on 14 Nov 2024
EPS came in at -$0.16 falling short of the estimated -$0.15 by -6.67%, while revenue for the quarter reached $2.35m , missing expectations by -7.44%.
Earnings released on 14 Aug 2024
EPS came in at -$0.19 falling short of the estimated -$0.17 by -11.76%, while revenue for the quarter reached $2.40m , missing expectations by -2.16%.
Earnings released on 15 May 2024
EPS came in at -$0.21 falling short of the estimated -$0.15 by -40.00%, while revenue for the quarter reached $2.41m , missing expectations by -5.28%.
Earnings released on 1 Apr 2024
EPS came in at -$0.26 falling short of the estimated -$0.20 by -30.00%, while revenue for the quarter reached $2.21m , beating expectations by +22.94%.
Earnings released on 14 Nov 2023
EPS came in at -$0.26 falling short of the estimated -$0.18 by -44.44%, while revenue for the quarter reached $298.48k , beating expectations by +198.48%.
Earnings released on 14 Aug 2023
EPS came in at -$0.20 falling short of the estimated -$0.13 by -53.85%, while revenue for the quarter reached $19.74k .
Earnings released on 15 May 2023
EPS came in at -$0.18 surpassing the estimated -$0.21 by +14.29%, while revenue for the quarter reached $921.00 , missing expectations by -99.08%.
Earnings released on 31 Mar 2023
EPS came in at -$0.20 falling short of the estimated -$0.19 by -5.16%, while revenue for the quarter reached $2.35k .
Earnings released on 14 Nov 2022
EPS came in at -$1.10 , while revenue for the quarter reached $1.15k .
Earnings released on 2 Sept 2022
EPS came in at -$0.03 , while revenue for the quarter reached $1.31k .
Earnings released on 31 Mar 2022
EPS came in at -$0.54 .
Earnings released on 31 Dec 2021
EPS came in at -$2.04 .
Earnings released on 30 Sept 2021
EPS came in at -$0.55 .
BIAF Stock Performance
Access detailed BIAF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
